Lv2
120 积分 2022-07-29 加入
Secukinumab for Giant Cell Arteritis
2个月前
已完结
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
2个月前
已完结
Emerging Era for Polymyalgia Rheumatica and GCA - Interleukin-17A Targeting
2个月前
已完结
Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
3个月前
已完结
From the grey area of pre-systemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosis
3个月前
已完结
From the grey area of pre-systemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosis
4个月前
已关闭
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project
6个月前
已完结
Idiopathic inflammatory myopathies related lung disease in adults
6个月前
已完结
Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review
6个月前
已完结
New Bitongling Ameliorates Joint Tissue Damage in Collagen-Induced Arthritis Mice by Suppressing Mapt Expression: A Genome-Wide Sequencing Study
8个月前
已完结
皖公网安备34019202002308
